Literature DB >> 23673348

Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population.

Masoud M Malekzadeh1, Arash Etemadi, Farin Kamangar, Hooman Khademi, Asieh Golozar, Farhad Islami, Akram Pourshams, Hossein Poustchi, Behrouz Navabakhsh, Mohammad Naemi, Paul D Pharoah, Christian C Abnet, Paul Brennan, Paolo Boffetta, Sanford M Dawsey, Alireza Esteghamati, Reza Malekzadeh.   

Abstract

BACKGROUND: There is considerable variation in hypertension prevalence and awareness, and their correlates, across different geographic locations and ethnic groups. We performed this cross-sectional analysis on data from the Golestan Cohort Study (GCS).
METHODS: Enrollment in this study occurred in 2004-2008, and included 50,045 healthy individuals from Golestan Province in northeastern Iran. Hypertension was defined as a SBP at least 140 mmHg, a DBP at least 90 mmHg, a prior diagnosis of hypertension, or the use of antihypertensive drugs. Potential correlates of hypertension and its awareness were analyzed by logistic regression adjusted for sex, age, BMI, place of residence, literacy, ethnicity, physical activity, smoking, black and green tea consumption and wealth score.
RESULTS: Of the total cohort participants, 21,350 (42.7%) were hypertensive. Age-standardized prevalence of hypertension, using the 2001 WHO standard world population, was 41.8% (95% confidence interval: 38.3-45.2%). Hypertension was directly associated with female sex, increased BMI, Turkmen ethnicity, and lack of physical activity, and inversely associated with drinking black tea and wealth score. Among hypertensive patients, 46.2% were aware of their disease, 17.6% were receiving antihypertensive medication, and 32.1% of the treated patients had controlled hypertension. Hypertension awareness was greater among women, the elderly, overweight and obese patients, and those with a higher wealth score.
CONCLUSION: Hypertension is highly prevalent in rural Iran, many of the affected individuals are unaware of their disease, and the rate of control by antihypertensive medications is low. Increasing hypertension awareness and access to health services, especially among less privileged residents are recommended.

Entities:  

Mesh:

Year:  2013        PMID: 23673348      PMCID: PMC3766446          DOI: 10.1097/HJH.0b013e3283613053

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  65 in total

Review 1.  Weaknesses and challenges of primary healthcare system in Iran: a review.

Authors:  Mahmoud Nekoei Moghadam; Vahideh Sadeghi; Sahar Parva
Journal:  Int J Health Plann Manage       Date:  2011-10-18

Review 2.  The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions.

Authors:  Eva Lonn; Jackie Bosch; Koon K Teo; Prem Pais; Denis Xavier; Salim Yusuf
Journal:  Circulation       Date:  2010-11-16       Impact factor: 29.690

3.  A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors.

Authors:  Masoud Majed; Sina Moradmand Badie
Journal:  Arch Iran Med       Date:  2011-01       Impact factor: 1.354

Review 4.  [Epidemiology and prevention of elderly hypertension].

Authors:  Taro Kojima; Yasuyoshi Ouchi
Journal:  Nihon Rinsho       Date:  2005-06

5.  Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial.

Authors:  S Yusuf; P Pais; R Afzal; D Xavier; K Teo; J Eikelboom; A Sigamani; V Mohan; R Gupta; N Thomas
Journal:  Lancet       Date:  2009-03-30       Impact factor: 79.321

6.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

7.  Antihypertensive and vasorelaxant effects of water-soluble proanthocyanidins from persimmon leaf tea in spontaneously hypertensive rats.

Authors:  Kayoko Kawakami; Saiko Aketa; Hiroki Sakai; Yusuke Watanabe; Hiroshi Nishida; Masao Hirayama
Journal:  Biosci Biotechnol Biochem       Date:  2011-08-07       Impact factor: 2.043

Review 8.  Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis.

Authors:  Thomas A Gaziano; Lionel H Opie; Milton C Weinstein
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

9.  A new look at old compounds.

Authors:  Silvestre Alavez; Gordon J Lithgow
Journal:  Aging (Albany NY)       Date:  2011-04       Impact factor: 5.682

Review 10.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.

Authors:  M R Law; J K Morris; N J Wald
Journal:  BMJ       Date:  2009-05-19
View more
  60 in total

1.  Hypertension and Pre-Hypertension Among Iranian Adults Population: a Meta-Analysis of Prevalence, Awareness, Treatment, and Control.

Authors:  Roghaiyeh Afsargharehbagh; Khadije Rezaie-Keikhaie; Hosien Rafiemanesh; Abbas Balouchi; Salehoddin Bouya; Behroz Dehghan
Journal:  Curr Hypertens Rep       Date:  2019-04-04       Impact factor: 5.369

2.  Avoidable Mortality Differences between Rural and Urban Residents During 2004-2011: A Case Study in Iran.

Authors:  Habib Omranikhoo; Abolghasem Pourreza; Hassan Eftekhar Ardebili; Hassan Heydari; Abbas Rahimi Forushani
Journal:  Int J Health Policy Manag       Date:  2013-11-15

3.  Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results.

Authors:  Abdullah Gandomkar; Hossein Poustchi; Maryam Moini; Mohsen Moghadami; Hadi Imanieh; Mohammad Reza Fattahi; Seyyed Mohammad Taghi Ayatollahi; Mohammad Mahdi Sagheb; Amir Anushiravani; Roozbeh Mortazavi; Sadaf Ghajarieh Sepanlou; Reza Malekzadeh
Journal:  Int J Public Health       Date:  2016-06-28       Impact factor: 3.380

4.  Comparison of anthropometric indices as predictors of the risk factors for cardiovascular disease in Iran: The PERSIAN Guilan Cohort Study.

Authors:  Marjan Mahdavi-Roshan; Arezoo Rezazadeh; Farahnaz Joukar; Mohammadreza Naghipour; Soheil Hassanipour; Fariborz Mansour-Ghanaei
Journal:  Anatol J Cardiol       Date:  2021-02       Impact factor: 1.596

5.  Cardiovascular disease mortality and years of life lost attributable to non-optimal systolic blood pressure and hypertension in northeastern Iran.

Authors:  Sadaf G Sepanlou; Roger B Newson; Hossein Poustchi; Masoud M Malekzadeh; Parisa Rezanejad Asl; Arash Etemadi; Hooman Khademi; Farhad Islami; Akram Pourshams; Paul D Pharoah; Christian C Abnet; Paul Brennan; Paolo Bofetta; Sanford M Dawsey; Farin Kamangar; Reza Malekzadeh
Journal:  Arch Iran Med       Date:  2015-03       Impact factor: 1.354

6.  The prevalence and predictors of pre-hypertension and hypertension in Kherameh cohort study: a population based study on 10,663 persons in south of Iran.

Authors:  Abbas Rezaianzadeh; Fatemeh Jafari; Seyed Ebrahim Sadeghi; Salar Rahimikazerooni
Journal:  J Hum Hypertens       Date:  2020-03-17       Impact factor: 3.012

7.  Prevalence and Risk Factors of Hypertension Among Young Adults in Albania.

Authors:  Benojir Ahammed; Md Maniruzzaman; Ashis Talukder; Farzana Ferdausi
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-10-28

8.  Hypertension: diagnosis, control status and its predictors in general population aged between 15 and 75 years: a community-based study in southeastern Iran.

Authors:  Hamid Najafipour; Hamid Reza Nasri; Mahdi Afshari; Mansoor Moazenzadeh; Mostafa Shokoohi; Afsaneh Foroud; Koorosh Etemad; Behnam Sadeghi; Ali Mirzazadeh
Journal:  Int J Public Health       Date:  2014-09-17       Impact factor: 3.380

Review 9.  Adiposity has a greater impact on hypertension in lean than not-lean populations: a systematic review and meta-analysis.

Authors:  Simin Arabshahi; Doreen Busingye; Asvini K Subasinghe; Roger G Evans; Michaela A Riddell; Amanda G Thrift
Journal:  Eur J Epidemiol       Date:  2014-05-17       Impact factor: 8.082

Review 10.  Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden.

Authors:  Karam Turk-Adawi; Nizal Sarrafzadegan; Ibtihal Fadhil; Kathryn Taubert; Masoumeh Sadeghi; Nanette K Wenger; Nigel S Tan; Sherry L Grace
Journal:  Nat Rev Cardiol       Date:  2017-09-21       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.